Pietro A Canetta Selected Research

Glomerulonephritis

1/2021	Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
1/2019	Kidney Transplantation in C3 Glomerulopathy: A Case Series.
10/2014	Rituximab treatment for fibrillary glomerulonephritis.
5/2012	Eculizumab for dense deposit disease and C3 glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro A Canetta Research Topics

Disease

10	Proteinuria 01/2022 - 01/2012
7	IGA Glomerulonephritis (IGA Nephropathy) 11/2023 - 01/2012
6	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021 - 01/2012
4	Glomerulonephritis 01/2021 - 05/2012
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 12/2013
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019 - 01/2012
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 10/2014
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 09/2012
2	Lupus Nephritis 01/2021 - 06/2013
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2019 - 05/2012
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019 - 01/2012
1	COVID-19 08/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 08/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Polyuria 01/2022
1	Heart Failure 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Hematoma 11/2020
1	Hematuria 11/2020
1	Hemorrhage 11/2020
1	Pain (Aches) 11/2020
1	Obesity 10/2020
1	Body Weight (Weight, Body) 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Glycosuria 05/2015
1	Paraproteinemias (Monoclonal Gammopathy) 07/2014
1	Celiac Disease (Celiac Sprue) 01/2014
1	Infections 01/2014
1	Nephritis 06/2013
1	Weight Gain 01/2012
1	Hyperglycemia 01/2012
1	Azotemia 06/2008
1	Acute Kidney Injury (Acute Renal Failure) 06/2008
1	Chronic Renal Insufficiency 06/2008

Drug/Important Bio-Agent (IBA)

10	CreatinineIBA 01/2022 - 06/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2008
4	Rituximab (Mabthera)FDA Link 01/2019 - 10/2014
3	Immunoglobulin A (IgA)IBA 01/2023 - 01/2014
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2014
3	SteroidsIBA 12/2013 - 01/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018 - 05/2012
2	AntibodiesIBA 04/2017 - 01/2014
2	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2013 - 01/2012
1	VaccinesIBA 08/2023
1	Muramidase (Lysozyme)IBA 08/2023
1	SodiumIBA 01/2022
1	HLA-DQ6 antigenIBA 01/2022
1	HLA-DR15 antigenIBA 01/2022
1	HLA-DQ5 antigenIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Serum AlbuminIBA 10/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019
1	AngiotensinsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 04/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2017
1	Tenofovir (Viread)FDA Link 05/2015
1	AlbuminsIBA 05/2015
1	Angiotensin IIIBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Bortezomib (Velcade)FDA Link 07/2014
1	1,2,3,4,6,7,8-heptachlorodibenzodioxinIBA 07/2014
1	Proteasome InhibitorsIBA 07/2014
1	AntigensIBA 01/2014
1	Glutens (Glutelin)IBA 01/2014
1	GliadinIBA 01/2014
1	Azathioprine (Imuran)FDA LinkGeneric 06/2013
1	AldosteroneIBA 09/2012
1	Valsartan (Vals)FDA Link 09/2012
1	aliskiren FDA Link 09/2012
1	eculizumab FDA Link 05/2012
1	Lipocalin-2IBA 06/2008

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2012
1	Conservative Treatment 11/2023
1	Extracorporeal Membrane Oxygenation 01/2022
1	Blood Transfusion (Blood Transfusions) 11/2020
1	Duration of Therapy 06/2013